In these patients, the presence of CD4+/CD8+ was predictive of ≥ grade 2 GVHD and they were sufficient to mediate xeno-GVHD pathology when retransplanted into naïve mice but provided no survival benefit when mice were challenged with a human B-ALL cell line [18]. The gene discussed is CD4; the disease is graft versus host disease.